Carlos Zgheib, PhD, MS
Room 4410
Dr. Zgheib co-leads the Laboratory for Fetal and Regenerative Biology (LFRB). He has an expansive background in leadership and almost 20 years of experience in biomedical research. He has extensive experience in regenerative medicine, tissue repair, nanotechnology and biomaterials.
His research encompasses a range of topics within the field of healing, response to injury, and regenerative medicine. He has overseen the development of multiple core technologies aiding in the treatment of unhealing wounds, acute lung injury and inflammatory bowel diseases.
Dr. Zgheib is a well published author with works in Acta Biomaterialia, NanoMedicine, International Journal of Molecular Sciences, and Frontiers in Immunology among others. He was the senior and lead author of many book chapters in the field of tissue regeneration.
Dr. Zgheib holds multiple U.S. and international patents and is the chief scientific officer of two biotech companies, Ceria Therapeutics and Silka Nanotechnologies. His research is currently funded by the National Institutes of Health.
Outside of medicine, Dr. Zgheib enjoys going on hikes, reading, experimenting in the kitchen, traveling, and discovering new places with his wife and son.
Degree(s)
- PhD: Medical Pharmacology and Toxicology, emphasis on targeting inflammation to promote tissue repair and regeneration
- MS: Pharmacology and Cosmetology
- MS: Biomedical Sciences
- BS: Biochemistry